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MATERIALS AND METHODS. Upon remodulation of blood flow (reperfusion) in the
donor renal transplant, a two-channel microdialysis polyurethane catheter has been
implanted in the kidney´s cortex (CMA70, CMA Microdialysis, Sweden). The intracellular
substrate (dializate) was collected in special 200 lL vials. The biochemical values have
been obtained with the help of CMA 600 Microdialysis (CMA Microdialysis AB, Stock-
holm, Sweden) analyzer. This research has been conducted over 38 h in the early post-
operative period with the biochemical values being read every hour. In the transplant’s
intertissue space, the following biochemical values were read: glucose, lactate, piruvate,
glycerol, and lactate/piruvate ratio. The data obtained has been presented as mean val-
ues ± r (p B 0,05 Student)
RESULTS. Having analyzed the results of the renal allotransplant dializate evaluation,
reference values have been established for the following biomarkers: glucose, lactate,
piruvate, glycerol, and lactate/piruvate ratio. A correlation between the renal transplant
dializate values and the function has been established. In 10 patients with the initial function
of the renal allotransplant, the values were: lactate -1,48 ± 0,26 mM, piruvate -
129,76 ± 23,20 lmol/L, lactate/piruvate ratio -11,81 ± 1,15; glycerol -
137,81 ± 32,92 lmol/L, and we determinated significant difference from those received
concerning 10 patients with delayed function of the renal transplant: lactate -
5,83 ± 1,08 mM, piruvate -213,75 ± 43,84 lmol/L, lactate/piruvate ratio -29,51 ± 4,64,
glycerol -342,33 ± 65,95 lmol/L during the entire period of observation.
CONCLUSIONS. Our accumulated experience proved that levels of lactate, glycerol, and
the lactate/piruvate ratio, received by means of microdialysis, present valuable prognostic
markers allowing for the evaluation of renal functions.
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INTRODUCTION. Renal dysfunction often occurred after liver transplantation.
OBJECTIVES. The aim of the study was to determine its incidence and its risk factors in a
clinical series at the University Hospital of Liege, Belgium.
METHODS. Orthotopic liver transplantations performed from January 2006 until Sep-
tember 2012 were retrospectively reviewed (n = 187). Patients, with no renal replacement
therapy (RRT) before transplantation were classified in four groups according to their
highest creatinine plasma level during the first postoperative week. First group had a cre-
atinine level below 12 mg/l, the second group between 12 and 20 mg/l, the third group
between 20 and 35 mg/l, and the fourth above 35 mg/l. In addition, patients who needed
RRT during the first week after transplantation were also classified in the fourth group.
Preoperative and perioperative parameters were tested as risk factors: age, sex, body mass
index (BMI), length of hospital preoperative stay, prior bacterial infection within one month,
preoperative ascites, preoperative treatment with ß-blocker, converting enzyme inhibitor, or
non steroidal antiinflammatory drugs, preoperative creatinine and bilirubine level, postop-
erative lactate level, need for postoperative vasopressive drugs, surgical revision,
mechanical ventilation for more than 24 h, postoperative peaks in bilirubine and transam-
inase levels, postoperative hemoglobin level, amount of perioperative blood transfusions,
type of immunosuppression. Univariate and multivariate analysis were performed using
logistic ordinal regression method.
RESULTS. There were 78 patients in group 1 (41.7 %), 46 in group 2 (24.6 %), 38 in group
3 (20.3 %) and 25 in group 4 (13.4 %). Eighteen patients required RRT: 13 (7 %) during the
first week after transplantation (group 4), the 5 others after the first week after transplan-
tation (2 in group 1 and 2, and 1 in group 3). There were 7 (3.7 %) early deaths within
28 days after transplantation. Using univariate analysis, the severity of renal dysfunction
was correlated with presence of ascites and prior bacterial infection, preoperative bilirubin
and creatinine level, need for surgical revision, use of vasopressor, postoperative mechanical
ventilation, postoperative bilirubine, transaminase, and hemoglobin levels. The need for
transfusion of each type of products also affected renal dysfunction. The ordinal logistic
analysis pointed out the BMI (OR = 1.1, p = 0.004), preoperative creatinine level
(OR = 11.1, p\ 0.0001), use of vasopressor (OR = 3.31, p = 0.0002), maximal postop-
erative bilirubine level (OR = 1.44, p = 0.044) and minimal postoperative hemoglobin
level (OR 0.059 p = 0.0005).
CONCLUSIONS.More than half of liver transplanted patients experienced some degree of
early renal dysfunction after transplantation. Risk factors are preoperative renal dysfunction,
and mainly perioperative circulatory instability requiring the use of vasopressor and post-
operative anemia.
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INTRODUCTION. Acute kidney injury may occur in patients undergoing major surgery
because of hypovolemia and reduced renal oxygen perfusion. Hypovolemia is commonly
treated with artificial solutions to decrease the need for allogenic blood tranfusions. A recent
experimental study has shown that haemodilution with crystalloids, in contrast to colloids,
induce intrarenal hypoxia (1).
OBJECTIVES. The aim of the study was to evaluate the differential effects of a crystalloid
and a colloid solution on renal perfusion, filtration and oxygenation, when used as post-
operative plasma volume expanders.
METHODS. Twenty-four patients with preoperatively normal renal function,
undergoing uncomplicated cardiac surgery, where studied in the ICU early after
surgery. Patients were randomized to receive either a balanced crystalloid (Ringers-
Acetate, 20 ml/kg, n = 12) or a colloid solution (HES 6 %, 130/0.4, 10 ml/kg,
n = 12) during 20-30 min. Effects on systemic haemodynamics (pulmonary artery
catheter) and renal variables were obtained before and 20, 40 and 60 min after
plasma volume expansion. Renal blood flow (RBF) and glomerular filtration rate
(GFR) were measured by the renal vein retrograde thermodilution technique and by
renal extraction of Cr-EDTA, respectively. Arterial and renal vein blood samples
were taken for measurements of arterial (CaO2) and renal vein (CrvO2) oxygen
contents. Renal oxygen consumption [RVO2 = RBF x (CaO2-CrvO2)], renal oxygen
delivery (RDO2 = RBF x CaO2) and renal oxygen extraction [RO2Ex = (CaO2-
CrvO2)/CaO2)] were calculated.
RESULTS. The plasma volume expansion was greater in the colloid group, compared
to the crystalloid group, as indicated by significantly lower haematocrit and CaO2, and
higher cardiac filling pressures. Urine flow increased significantly (170 %) only in the
crystalloid group. Cardiac index and RBF increased by 15 % respectively 5-10 %, in
both groups (ns). In neither one of the groups did plasma volume expansion render a
change in RDO2. GFR increased to a similar extent with both fluids. In the crystalloid
group, there was a significant increase in both RVO2 and RO2Ex, which was not seen in
the colloid group (see figure).
[Fig 1: Renal oxygen extraction and consumption]
CONCLUSION. Postoperative plasma volume expansion with a crystalloid and a colloid
solution both increases GFR. Despite the increase in cardiac index and RBF caused by both
fluids, none of them increased RDO2, due to the haemodilution. Crystalloids, in contrast to
colloids, impair the renal oxygen demand/supply relationship, i.e. renal oxygenation, as
demonstrated by an increase in renal oxygen extraction. This clinical study support recent
experimental findings that acutely expanded plasma volumeacute plasma volume expansion
with crystalloid, but not with colloid, impair renal oxygenation.
REFERENCE. 1. Konrad et al. Acute normovolemic hemodilution in the pig is associated
with renal tissue edema, impaired renal microvascular oxygenation, and functional loss.
Anesthesiology 2013;119:256-69
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INTRODUCTION. Colistin is widely used in resistant gram-negative bacterial infections.
The common side effect of colistin is nephrotoxicity, 14 %-55 % reported. Risk factors for
nephrotoxicity are advanced age, nephrotoxic agent usage and chronic renal failure in
general population.
OBJECTIVES. The aim is to identify the risk factors for acute kidney injury in sepsis
patients treated with colistin.
METHODS. Gram- negative sepsis patients admitted to ICU in two years were analyzed
retrospectively. APACHE II, the presence of shock, initial glomerular filtration rate, the
duration of colistin administration, simultaneous nephrotoxic agent administration (NSAID,
antibiotics) were recorded. Acute renal injury was classified according to RIFLE criteria.
Patients with chronic renal failure were excluded.
RESULTS. 64 (32 male, 32 female) gram-negative sepsis patients were evaluated. Acute
kidney injury was detected in 56 (87 %) patients. 42 patients out of 56 were administered
colistin and the mean duration of administration was 6,43 days. The distribution of acute
kidney injury in patients using colistin is given in Table 1. Acute kidney injury was sig-
nificantly higher in colistin, nephrotoxic agent, shock (+) patients compared to colistin,
nephrotoxic agent (+) shock (-) patients (p:0,049). In the presence of shock, acute kidney
injury was higher in patients using colistin but not nephrotoxic agent according to patients
without shock (p:0,023). In septic shock patients using colistin, there is no difference in
acute kidney injury between patients with nephrotoxic agent and without nephrotoxic agent
usage (p:0,367). 57 % of the patients using colistin who developed acute kidney injury were
in the Failure (F) group according to RIFLE criteria. Acute kidney injury was significantly
higher in septic shock patients who were using colistin compared to septic shock patients
who were not using colistin (p:0,0001).
CONCLUSIONS. The incidence of acute kidney injury classified according to RIFLE
criteria is high in sepsis patients. New onset acute kidney injury is correlated with the
presence of shock and colistin usage but not with simultaneous nephrotoxic agent usage.
The presence of shock is a risk factor for acute kidney injury in sepsis patients treated with
colistin.
REFERENCES. 1) Rocco M, Montini L, Alessandri E et al. Risk factors for acute kidney
injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate
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INTRODUCTION. Increased serum procalcitonin after cardiac surgery is associated with
prolonged LOS in ICU and negative clinical outcome. But the real mechanisms of such
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